<h1>MARAX</h1><p>
MARAX (ephedrine sulfate, theophylline,
hydroxyzine HCl)
TABLETS,Each Tablet Contains:
Ephedrine Sulfate. ....................................................................................25 mg
Theophylline. ........................................................................................130 mg
Atarax® (Hydroxyzine HCl). ........................................................................10 mg
Inert ingredients are: alginic acid; magnesium stearate; precipitated calcium carbonate; sodium
lauryl sulfate.
ACTIONS
The action of ephedrine as a vasoconstrictor is well known. It is therefore of significant benefit in
symptomatic relief of the congestion occurring in bronchial asthma. As a bronchodilator, it has a
slower onset but longer duration of action than does epinephrine, which, in contrast to ephedrine,
is not effective upon oral administration.
The diverse actions of theophylline—bronchospasmolytic, cardiovascular, and diuretic—are well
established, and make it a particularly useful drug in the treatment of bronchial asthma, both in
the acute attack and in the prophylactic therapy of the disease.
Atarax (hydroxyzine HCl) modifies the central stimulatory action of ephedrine preventing
excessive excitation in patients on Marax therapy.
In animal studies Atarax has demonstrated antiserotonin activity and antispasmodic potency of a
nonspecific nature.
</p>
MARAX (ephedrine sulfate, theophylline,
hydroxyzine HCl)
TABLETS,Each Tablet Contains:
Ephedrine Sulfate. ....................................................................................25 mg
Theophylline. ........................................................................................130 mg
Atarax® (Hydroxyzine HCl). ........................................................................10 mg
Inert ingredients are: alginic acid; magnesium stearate; precipitated calcium carbonate; sodium
lauryl sulfate.
ACTIONS
The action of ephedrine as a vasoconstrictor is well known. It is therefore of significant benefit in
symptomatic relief of the congestion occurring in bronchial asthma. As a bronchodilator, it has a
slower onset but longer duration of action than does epinephrine, which, in contrast to ephedrine,
is not effective upon oral administration.
The diverse actions of theophylline—bronchospasmolytic, cardiovascular, and diuretic—are well
established, and make it a particularly useful drug in the treatment of bronchial asthma, both in
the acute attack and in the prophylactic therapy of the disease.
Atarax (hydroxyzine HCl) modifies the central stimulatory action of ephedrine preventing
excessive excitation in patients on Marax therapy.
In animal studies Atarax has demonstrated antiserotonin activity and antispasmodic potency of a
nonspecific nature.
</p>
